Why Investors Plowed Into Viking Therapeutics Stock Today [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
For the second day in a row , a pundit's take on Viking Therapeutics (NASDAQ: VKTX) helped push the biotech's share price higher. It was this rather than inherent news from the company that added more than 3% to said price, a gain that handily beat the S&P 500 index's 0.8% increase. Thumbs-up from bullish pundit The latest analyst to weigh in on Viking's prospects was Morgan Stanley 's Michael Ulz, who early Thursday morning published a new research note on the now-prominent biotech. Ulz is unquestionably a Viking bull, as his recommendation on the stock is overweight (read: buy) at a relatively high $105 per-share price target -- 67% above the stock's latest closing price. These days, investors are eager for news of the company's VK2735 investigational obesity drug. If successful, this treatment should compete quite effectively with similar medications commercialized by Denmark-based Novo Nordisk (NYSE: NVO) and American company Eli Lilly (NYSE: LLY) , not least because it is
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider [Yahoo! Finance]Yahoo! Finance
- Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now. [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735 [Yahoo! Finance]Yahoo! Finance
- Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic? [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $105.00 price target on the stock.MarketBeat
VKTX
Earnings
- 7/24/24 - Beat
VKTX
Sec Filings
- 9/20/24 - Form 144
- 9/20/24 - Form 144
- 8/22/24 - Form 4
- VKTX's page on the SEC website